This discussion examines the critical link between suicidality and the menstrual cycle, including evidence showing increased risk during the perimenstrual phase. Panelists will explore current research, clinical understanding in conditions such as premenstrual dysphoric disorder and premenstrual exacerbation, and ongoing efforts to improve diagnostic recognition.

The session also highlights future directions for suicide prevention through treatment innovation, provider education, advocacy, and enhanced clinical care for individuals affected by hormone-related mood disorders.